KREMEN1 Knockout Cell Line-RKO

Product Name	KREMEN1 Knockout Cell Line-RKO
Cat.No	RK-0003
Size	1*10^6 cells/vial
Description	KREMEN1 Knockout Cell Line, Knockout achieved by using CRISPR/Cas9. Knockout region: Exon 2 (based on transcript KREMEN1-202). PCR+Sanger Sequencing are used for knockout validation. This KO cell line product includes the genetically modified cell line and Matched control (Free of charge wild type control available). .
Species	Human
Gene name	KREMEN1
Gene id	83999
Parental Cell Line	RKO
Biosafety Level	BSL 1. Runtogen determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services.
Morphology	Epithelial-like, adherent
Passage Ratio	1:2~1:4
Culture Method	90%DMEM+10%FBS
Quality Control	KREMEN1 Knockout Cell Line is negative for mycoplasma, bacteria, yeast, and fungi.
Shipping	Cryopreserved cells are shipped with dry ice
Storage	Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
Warranty	The KO cell product is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA.
Disclaimers	This cell product is intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen.

KREMEN1 Knockout Cell Line-RKO

Online Inquiry

Online Inquiry